Cytodyn Inc (CYDY)

[studhoss]

I work in a chemical plant. But about a 100 years ago I took a statistics and methods class in college. At this point I think the appropriate way to evaluate CytoDyn would be to do a sort of meta analysis. There is a lot of anecdotal evidence showing leronlimab to be very effective. But since the numbers are small on each situation and the methodology not rigorous, it could be luck. Now this macaque monkey study doesn't have a control group and as you stated Cytodyn could have just gotten very lucky once again. But it seems to me that they are getting lucky too regularly for it to be just chance every time. Any single roll of the dice could be dumb luck. But after the shooter rolls 7's 10 ot 15 times in a row, you kind of have to start wondering if those old bones aren't loaded with real efficacy.

The thing I would really like to know is what's motivating all the players in these short attacks. Are they keeping the price low so someone employing them can acquire a fat block? Are they making money on the swings? Are they really nothing more than unscrupulous short sellers? Or is there some other impetus I've yet to think of?Whatever it is, I really hope the SEC goes after them. Meanwhile, I'll ride my 80K shares like a rollercoaster. CytoDyn looks to me like the deal of the century. I could be wrong about that, of course, but I'm not uncertain. Time will tell.